4.8 Article

TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD

Journal

SCIENCE
Volume 349, Issue 6248, Pages 650-655

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aab0983

Keywords

-

Funding

  1. Robert Packard Center for ALS Research, Muscular Dystrophy Association
  2. Amyotrophic Lateral Sclerosis Association
  3. Target ALS
  4. Johns Hopkins University Neuropathology Pelda fund
  5. Johns Hopkins Alzheimer's Disease Research Center [NIH P50AG05146]
  6. Samuel I. Newhouse Foundation

Ask authors/readers for more resources

Cytoplasmic aggregation of TDP-43, accompanied by its nuclear clearance, is a key common pathological hallmark of amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). However, a limited understanding of this RNA-binding protein (RBP) impedes the clarification of pathogenic mechanisms underlying TDP-43 proteinopathy. In contrast to RBPs that regulate splicing of conserved exons, we found that TDP-43 repressed the splicing of nonconserved cryptic exons, maintaining intron integrity. When TDP-43 was depleted from mouse embryonic stem cells, these cryptic exons were spliced into messenger RNAs, often disrupting their translation and promoting nonsense-mediated decay. Moreover, enforced repression of cryptic exons prevented cell death in TDP-43-deficient cells. Furthermore, repression of cryptic exons was impaired in ALS-FTD cases, suggesting that this splicing defect could potentially underlie TDP-43 proteinopathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available